Glioblastoma
RecruitingStudy on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients
- Disease:Glioblastoma
- Substances:Temozolomide
Austria- Participants:18–64 years · 65+ years
- Substances:Temozolomide
- Sponsor:Region Oestergoetland
Rare diseases
Investigational molecules
Locations
Back to Austria95 clinical trials in St. Poelten, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
AustriaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer, multiple myeloma, and lymphoma treatments. Studies include evaluating new therapeutic approaches for hormone-receptor-positive breast cancer and novel combinations for blood cancers.
Several trials are exploring targeted therapies and immunotherapy combinations for better patient outcomes.
Research targeting atopic dermatitis and inflammatory bowel diseases including Crohn's disease and ulcerative colitis. Studies evaluate new treatment options for managing chronic inflammatory conditions.
Trials focus on both adolescent and adult populations, investigating long-term safety and efficacy.
Investigations into preventing stroke and managing cardiac conditions. Research includes novel anticoagulation approaches and treatments for atrial fibrillation.
Studies evaluate both preventive measures and acute treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.